[Tocolysis and its place in premature labor]

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine

Background:

• Premature labor affects 6-8% of deliveries, causing 75-80% of perinatal infant mortality.
• Effective interventions are crucial to improve neonatal outcomes and reduce mortality.

Purpose of the Study:

• To evaluate the efficacy of tocolytic therapy for progressing premature labor.
• To compare different tocolytic agents and their impact on maternal and infant morbidity/mortality.
• To define successful tocolysis as delaying delivery by at least 48 hours.

Main Methods:

• Comparison of beta-adrenomymetics versus magnesium sulfate for tocolysis.
• Assessment of adding Indomethacin to standard tocolytic treatment.
• Monitoring maternal and infant outcomes, including birth weight and respiratory distress.

Main Results:

• No significant difference in tocolysis success rates between beta-adrenomymetics and magnesium sulfate.
• Improved tocolysis outcomes observed when Indomethacin was added to the primary therapy.
• Tocolytic therapy was associated with increased newborn birth weight and reduced respiratory distress compared to expectant management.

Conclusions:

• Tocolytic therapy is beneficial in managing progressing premature labor.
• Indomethacin may enhance the effectiveness of standard tocolytic treatments.
• Tocolytic therapy appears safe for mothers and infants, potentially improving neonatal health outcomes.